Bli medlem
Bli medlem

Du är här


IK Investment Partners: IK Investment Partners to acquire ZytoService

IK Investment Partners ("IK") is pleased to announce that the IK VIII
Fund has reached an agreement to acquire ZytoService Group
("ZytoService" or "the Company"), a leading compounder of
pharmaceuticals for patient-individualised infusions, from the
founders and Capiton. Financial terms of the transaction are not

Founded in 2002, ZytoService is one of the largest industrially
organised §13 AMG (`Arzneimittelgesetz') certified compounders for
patient-individualised infusions applied mainly in oncology treatment
in Germany. The Company is based in Hamburg, where it runs a
state-of-the-art compounding facility.

"We are delighted to be working with IK going forward. ZytoService
operates in an industry in which IK has extensive expertise, and with
their support we will be well placed to further expand our competence
and provide the best service to our customers," said Enno Scheel,
Co-Founder of ZytoService.

"We firmly believe in the strengths of partnering with IK. Together,
we will continue investing in the business to better address the
growing demands of the German healthcare market," added Thomas Boner,
Co-Founder of ZytoService.

Mr Enno Scheel and Mr Thomas Boner, Co-Founders and Co-CEOs of
ZytoService will remain with the business in managerial roles, and
will be shareholders alongside IK.

"Thanks to IK's experience in the relevant sector, we quickly
recognised ZytoService's potential. We look forward to backing the
management team and expanding the Company's operational capabilities.
We believe ZytoService is ideally positioned to develop further and
provide highest quality services to its customers," said Detlef
Dinsel, Managing Partner at IK and advisor to the IK VIII Fund.

Completion of the transaction is subject to custom legal and
regulatory approvals.

ZytoService will be the second investment of the 2016 established IK
VIII Fund.

For further questions:

Thomas Bonner, Co-Founder and Co-CEO
Phone: +49 40 600 094 013

Enno Scheel, Co-Founder and Co-CEO
Phone: +49 40 600 094 013

IK Investment Partners
Detlef Dinsel, Managing Partner
Phone: +49 40 369 88 50

Mikaela Hedborg, Communications & ESG Manager
Phone: +44 77 87 573 566

About ZytoService
ZytoService operates as a leading compounder of patient-individualised
infusions, specialising mainly on the field of oncology. The Company
conducts its compounding operations at a state-of-the art facility
located in Hamburg, in accordance with §13 AMG (`Arzneimittelgesetz')
regulation. For more information please visit

About IK Investment Partners
IK Investment Partners ("IK") is a Pan-European private equity firm
focused on investments in the Nordics, DACH region, France and
Benelux. Since 1989, IK funds have raised more than €7.5 billion of
capital and invested in over 100 European companies. IK funds support
businesses with strong underlying potential, partnering with
management teams to create robust, international leaders with
excellent long-term prospects. For more information, please visit


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.